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Protein biogenesis and importMitochondria are involved in many essential cellular activities. These broad functions explicate the
need for the well-orchestrated biogenesis of mitochondrial proteins to avoid death and pathological
consequences, both in unicellular and more complex organisms. Yeast as a model organism has
been pivotal in identifying components and mechanisms that drive the transport and sorting of
nuclear-encoded mitochondrial proteins. The machinery components that are involved in the
import of mitochondrial proteins are generally evolutionarily conserved within the eukaryotic king-
dom. However, topological and functional differences have been observed. We review the similari-
ties and differences in mitochondrial translocases from yeast to human. Additionally, we provide a
systematic overview of the contribution of mitochondrial import machineries to human patholo-
gies, including cancer, mitochondrial diseases, and neurodegeneration.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Mitochondria are semi-autonomous organelles that possess
their own DNA and translational machinery. This is the legacy from
their mitochondrial ancestor, the endosymbiotic proteobacterium
[1]. Mitochondrial DNA encodes only a handful of proteins that
are central to the process of oxidative phosphorylation. Therefore,
the mitochondrial proteome, which consists of approximately 800
(in yeast) to 1500 (in mammals) proteins, needs to be substantially
complemented with nuclear-encoded proteins [2,3]. Upon synthe-
sis on cytosolic ribosomes, immature mitochondrial precursor pro-
teins require chaperone-assisted transfer to the mitochondrial
surface. The sorting of precursors within mitochondria is an intri-
cate process because of the complex architecture of the organelle
[4]. Mitochondria are surrounded by two membranes that are
highly divergent with regard to their function and lipid and protein
composition. Both the outer mitochondrial membrane (OMM) and
inner mitochondrial membrane (IMM) deﬁne two aqueous mito-
chondrial subcompartments, the intermembrane space (IMS) and
the matrix. To reach their destined mitochondrial milieu, precursor
proteins are driven by various import machineries to differentmitochondrial compartments. This trafﬁcking is based on sorting
signals included within the precursors’ primary or secondary
structures [5–8].
2. Principles of mitochondrial protein import: lessons from
yeast
Extensive studies of mitochondrial protein import using the
model yeast Saccharomyces cerevisiae uncovered the components
of different translocases and provided detailed mechanistic and
topological information about their function and interplay [5–8].
The translocase of the outer mitochondrial membrane (TOM) com-
plex is a general entry gate for mitochondrial precursor proteins
that are synthesized in the cytosol (Fig. 1A). Its components recog-
nize a precursor protein and pass it to specialized import machin-
eries. The precursors of b-barrel proteins are sorted to the OMM by
sorting and assembly machinery (SAM; Fig. 1A). The import of
small IMS proteins with multiple cysteine residues occurs because
of the thiol-disulﬁde exchange via the mitochondrial intermem-
brane space assembly (MIA) pathway (Fig. 1B). The translocase of
the inner mitochondrial membrane 23 (TIM23) complex directs
presequence-containing precursors to the matrix, IMM, or IMS
(Fig. 1C). Metabolite carriers that reside in the IMM and contain
multiple internal transmembrane signals are embedded into the
Fig. 1. Protein transport pathways into yeast Saccharomyces cerevisiae mitochondria. (A) General entry gate for mitochondrial precursor proteins and sorting into the outer
mitochondrial membrane (OMM). Mitochondrial proteins are synthesized in the cytosol in precursor forms. Their delivery to the mitochondrial surface is assisted by cytosolic
chaperones that maintain precursor proteins in an import-competent state. Precursors enter mitochondria through the translocase of the outer membrane (TOM), the general
entry gate, and are further directed to their ﬁnal mitochondrial destinations with assistance from speciﬁc sorting machineries. Precursor proteins that contain a-helical
transmembrane segments are inserted into the OMM by the insertase of the mitochondrial outer membrane (MIM) for assembly. More complex precursors with b-barrel
topology are transported via TOM into the intermembrane space (IMS) and handed over to the sorting and assembly machinery (SAM) with the help of small Tim chaperone
complexes. (B) Oxidation-driven import into the intermembrane space (IMS). Cysteine-rich precursor proteins are delivered into the IMS via the mitochondrial
intermembrane space assembly (MIA) pathway. Emerging from the TOM complex, they transiently bind Mia40 via disulﬁde bonds. Mia40 oxidizes and folds precursor
proteins. The reoxidation of Mia40 is mediated by Erv1, which shuttles released electrons via cytochrome c to cytochrome c oxidase (complex IV). (C) Translocation to the
matrix and inner mitochondrial membrane (IMM). Presequence-containing precursors are delivered to the matrix and inner membrane in an inner membrane
electrochemical potential (Dw)-dependent manner via the presequence translocase TIM23. TIM23 is associated with the presequence translocase-associated motor (PAM)
and transfers precursor proteins into the matrix in an ATP-dependent manner. The insertion of presequence-containing precursors into the inner membrane is driven by the
TIM23SORT complex, marked by the presence of Tim21. Upon delivery into the matrix, the presequences are recognized and cleaved by matrix-processing peptidase (MPP).
The hydrophobic precursors of carrier proteins are guided through the IMS by small TIM chaperone complexes that deliver precursors to the carrier translocase of the inner
membrane, the TIM22 complex. The membrane insertion of carrier precursors via the TIM22 complex is driven by the electrochemical potential across the inner membrane.
The mitochondrial protein export machinery (OXA) participates in the biogenesis of some cytosol-translated multispanning membrane proteins that are targeted to the IMM
via the TIM22 and TIM23 translocases. e, electron.
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brane 22 (TIM22) complex [5–8] (Fig. 1C).
2.1. Yeast outer membrane translocase: a closer look
All mitochondrial precursors enter the organelle in an unfolded,
import-competent state via the TOM complex [9–11] (Fig. 1A). The
central component and a channel-forming subunit of the TOM
complex is a membrane b-barrel protein, Tom40. Additionalsubunits perform important functions in maintaining the architec-
ture of the TOM complex and passage of precursor proteins. Tom20
and Tom70 are membrane-anchored proteins that are loosely asso-
ciated with the TOM complex. Through their cytosol-exposed
C-terminal domains, they serve as receptors for various classes of
incoming precursor proteins. Tom22 is a core subunit of TOM
and performs two essential functions. First, Tom22 maintains the
architecture of the TOM complex. Second, it provides further bind-
ing sites for mitochondrial precursor proteins on both sides of the
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Tom5, Tom6, and Tom7. Additionally, Tom5 directly participates
in the transfer of precursors [9–11]. Mitochondrial precursor pro-
teins are recognized and transferred into the mitochondrial inte-
rior through the TOM complex and subsequently directed to
their ﬁnal submitochondrial location by respective downstream
machineries.
2.2. Biogenesis of b-barrel and a-helical proteins of the OMM
The OMM of mitochondria possesses a class of membrane pro-
teins with b-barrel topology, such as Tom40 and porins (VDAC).
The machinery responsible for the assembly and OMM integration
of b-barrel proteins is the SAM complex [5,9,10,12]. Initially,
b-barrel precursors are translocated through TOM into the IMS
where they are assisted by the Tim9-Tim10 and Tim8-Tim13 chap-
erone complexes to reach the SAM. Recognition by the SAM com-
plex is driven by the signal embedded in the primary structure of
b-barrel substrate proteins, called b-signal. The SAM complex con-
sists of three core components, Sam50, Sam35, and Sam37
(Fig. 1A). Sam50 and Sam37 are essential in yeast. Sam50 with a
POTRA domain cooperates with Sam35 and Sam37 in the recogni-
tion, transfer, and release of b-barrel proteins into the lipid bilayer
(Fig. 1A). Additionally, the SAM complex associates with Mdm10,
which is speciﬁcally required in the late stage of TOM complex
assembly [5,9,10,12]. The effectiveness of protein sorting is
improved by the coupling of TOM and SAM because they are not
independently acting machineries [13]. Outer mitochondrial mem-
brane proteins that are embedded in the OMMwith the help of one
or more a-helical transmembrane segments use TOM complex
receptors in a unique way, in which they do not appear to be direc-
ted to the protein-conducting channel of TOM. Instead, these pro-
teins are sorted via the mitochondrial import complex, MIM, into
the OMM. MIM functions as a heterooligomeric complex that com-
prises two subunits, Mim1 and Mim2 [7–9,11] (Fig. 1A). Recently,
the abundant OMM protein, Om45, was shown to be integrated to
the OMM from the IMS site with the involvement of the IMM
machinery, TIM23 [14,15].
2.3. Oxidation-driven import into the IMS
The biogenesis of small IMS proteins proceeds via the MIA path-
way [10,16–19] (Fig. 1B). Interestingly, small IMS proteins are reg-
ulated by the ubiquitin-proteasome system prior to their
mitochondrial import via MIA [20]. Mitochondrial intermembrane
space assembly substrates are small soluble proteins that share a
characteristic feature of cysteine residues, typically arranged in
CX3C and CX9C motifs. An example of MIA substrates with a
CX3C motif are small Tim proteins, whereas many other proteins,
including components involved in the biogenesis of cytochrome c
oxidase, Cox17 and Cox19, contain a CX9C motif. The formation
of disulﬁde bonds between the cysteine residues upon import into
the mitochondria stabilizes the folded structure of these proteins
and prevents their leakage from mitochondria.
The MIA import pathway is responsible for the catalytic forma-
tion of disulﬁde bonds within substrates, thereby coupling the
import of precursor proteins with their oxidative folding inside
the IMS [10,16–19]. The essential components of the MIA machin-
ery are Mia40 oxidoreductase and the sulfhydryl oxidase Erv1.
Mia40 is anchored in the IMM, exposing the C-terminal domain
into the IMS (Fig. 1B). Serving as a trans-receptor, Mia40 speciﬁ-
cally recognizes and transiently forms disulﬁde bonds with
reduced precursors that emerge from the TOM channel. Speciﬁcity
is ensured by the presence of mitochondrial intermembrane space
sorting signals within IMS proteins, known as MISS/ITS. These
signals direct the hydrophobicity-driven positioning of a speciﬁcprecursor’s cysteine residue that forms a transient disulﬁde bond
with the redox active Mia40. The efﬁcient recognition of a precur-
sor by Mia40 is promoted by the localization of Mia40 in close
proximity to TOM. The Mic60 (Fcj1/Mitoﬁlin) protein, a component
of the mitochondrial contact site and cristae-organizing system
MICOS (MINOS/MitOS), plays a role in Mia40 positioning as it binds
both Mia40 and TOM [19,21].
The formation of a transient complex between Mia40 and its
substrates is an important initial step in the oxidation-coupled bio-
genesis of IMS proteins [10,16–19] (Fig. 1B). Upon the transfer of a
disulﬁde bond fromMia40 to the substrate, the CPC motif of Mia40
is reduced and subsequently reoxidized by sulfhydryl oxidase Erv1
to be ready for the next round of substrate binding. This simple
function of Erv1 in disulﬁde relay is well proven by in vitro and
structural data. However, in vivo experiments demonstrated that
Erv1 forms a transient ternary complex with Mia40 and a substrate
that promotes its efﬁcient release in a fully oxidized form that typ-
ically contains two disulﬁde bonds. Electrons that are received in
the course of IMS oxidation reactions are transferred from the pre-
cursor proteins through Mia40 and the redox centers of Erv1,
including FAD cofactor to cytochrome c and respiratory chain com-
plex IV, before they reach molecular oxygen as a ﬁnal acceptor
[10,16–19] (Fig. 1B). In addition to the biogenesis of small IMS pro-
teins, Mia40 functions as a disulﬁde carrier and chaperone that
supports the biogenesis of non-canonical substrates, including
the integral membrane protein Tim22, peripheral membrane-
bound Atp23, and matrix-localized Mrp10 [22–24].
2.4. Import of precursor proteins with a cleavable presequence
Over half of all mitochondrial precursor proteins are synthe-
sized with targeting signals at their N-termini, which are called
presequences, and cleaved inside mitochondria [25]. One charac-
teristic feature of presequences is their a-helical structure with
positively charged and hydrophobic surfaces (Fig. 1C). After cross-
ing the TOM channel, precursors are directed to the TIM23 com-
plex [6,26–30]. The TIM23 or presequence pathway is utilized by
proteins that are targeted to the matrix and also partially by pro-
teins that are localized to the IMM and IMS. Import via the prese-
quence pathway occurs in an IMM electrochemical potential- and
adenosine triphosphate (ATP)–dependent manner. The TIM23
complex is composed of three essential IMM proteins, Tim50,
Tim23, and Tim17. Tim50 serves as a receptor in the initial stages
when precursors are passed from TOM to the TIM23 channel.
Tim23 and Tim17 have multiple transmembrane helices and form
a core channel part of the complex (Fig. 1C). The electrochemical
potential of the IMM plays an important role in protein transloca-
tion through TIM23 by exerting an electrophoretic force on the
positively charged presequence. Additionally, conformational rear-
rangements of these components in response to electrochemical
potential provide the means to sense and regulate the gating of
the TIM23 channel [6,26–31].
TIM23 associates with the presequence translocase-associated
motor (PAM) to guide presequence precursors into the matrix
[6,26–30]. mtHsp70 (Ssc1) is a central component of PAM that
binds precursor proteins and utilizes ATP, thereby contributing to
their movement inside the organelle (Fig. 1C). Tim44 is peripher-
ally associated with IMM and mediates mtHsp70 attachment to
TIM23. Additionally, PAM consists of an array of co-chaperones
and helper proteins, including the J-proteins Pam18 and Pam16,
the nucleotide exchange factor Mge1, and Pam17, which assists
with the recruitment of Pam18 and Pam16 to TIM23 (Fig. 1C).
In addition to the TIM23-PAM complex, another version, called
TIM23SORT, exists that is functionally different from TIM23-PAM
[6,27,29] (Fig. 1C). TIM23SORT is capable of the IMM insertion of
presequence proteins if the presequence is followed by the
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ence is underscored by changes in the architecture of the complex,
in which the PAM complex is substituted by Tim21. Tim21 plays an
important role in the productive transfer of precursor proteins
from TOM to TIM23 and bridging of TIM23 with respiratory chain
complexes III and IV. Its interaction with TIM23 is supported by the
presence of Mgr2 (Fig. 1C). In addition to Tim21 and Mgr2, Tim17
was also shown to play an important role in the lateral sorting of
membrane precursor proteins [6,26–30].
The presequence-containing precursor proteins undergo vari-
ous maturation steps [25]. The most important and common event
for a large majority of these proteins is the removal of a positively
charged presequence, frequently just upon its appearance on the
matrix side of TIM23 (Fig. 1C). This important step is executed by
mitochondrial processing peptidase (MPP). Some matrix-localized
proteins require further processing by Icp55 or Oct1 to gain stable
forms. The TIM23 complex is also utilized by a subset of prese-
quence-containing precursors that are targeted to the IMS. These
precursors contain the classical MPP-cleavable presequence, fol-
lowed by a transmembrane domain that is cleaved by the inner
membrane protease (IMP) at the IMS side of IMM. Upon the second
cleavage, the mature form of the protein is released into the IMS in
a soluble form [25].
2.5. Import of proteins with multiple internal signals
A separate IMM translocase, called TIM22, is specialized in the
biogenesis of hydrophobic proteins of the carrier family and other
multispanning IMM proteins, including translocase components
Tim23, Tim22, and Tim17 [5,27,32,33]. This group contains multi-
ple hydrophobic segments that are dispersed throughout their
polypeptide chain and is not proteolytically processed upon their
IMM integration. The biogenesis of metabolite carrier precursors
requires the assistance of cytosolic chaperones that are engaged
in the efﬁcient passage of newly synthesized precursors and pre-
vent their aggregation. Upon recognition by Tom70 and ATP
hydrolysis, the chaperones are released, and the precursors are
handed over to the Tom40 channel to be transferred in a loop for-
mation (Fig. 1C). Once on the IMS side, the aggregation of hydro-
phobic precursors is prevented by binding to small Tim
chaperone complexes, Tim9-Tim10 or Tim8-Tim13. The hydro-
phobic precursors are delivered to TIM22 with help from the
Tim9-Tim10-Tim12 complex that is peripherally bound to
TIM22 (Fig. 1C). Tim22, a core subunit of TIM22, forms a pore
and promotes precursor insertion into the lipid bilayer in a mem-
brane potential-dependent fashion. Tim22 associates with Tim54
to form the fully functional translocase (Fig. 1C). The receptor role
of Tim54 is fulﬁlled by a large C-terminal domain that is exposed
to the IMS. Two other proteins, Tim18 and Sdh3, form a module
that is a stoichiometric part of the TIM22 translocase. Interest-
ingly, Sdh3 is part of the succinate dehydrogenase complex (com-
plex II) of the respiratory chain, where it builds an analogous
subcomplex with Sdh4 (Tim18 homologue). The precise role of
the Tim18-Sdh3 module in membrane integration is currently
unknown. This is yet another example of links between energy-
transducing complexes and protein translocation machineries
[27,33].
Oxa1, the homologue of bacterial YidC protein conserved
between species, is a core component of the mitochondrial protein
export machinery (OXA) involved in the co-translational import of
mitochondrially-encoded proteins into the IMM [5,34]. Addition-
ally, Oxa1 has been shown to participate in the posttranslational
transport of multispanning proteins into the IMM, reﬂecting the
cooperation of Oxa1 with the TIM22 and TIM23 translocases
[35,36] (Fig. 1C).3. Architecture and function of mitochondrial protein
translocases in evolution
Mitochondrial protein import machineries have been inten-
sively studied, both at the molecular and mechanistic levels. How-
ever, most of our current knowledge stems from studies that were
performed on the yeast S. cerevisiae as a model organism. High evo-
lutionary conservation of the import components within the
eukaryotic kingdom is a striking feature of mitochondrial translo-
cases (Fig. 2). In this chapter, we review the human mitochondrial
translocases and discuss differences between yeast and mamma-
lian mitochondrial import systems.
3.1. Biogenesis of outer membrane proteins
The human TOM complex consists of TOMM40, TOMM22,
TOMM20, TOMM70A, TOMM5, TOMM6, and TOMM7 (Fig. 2A).
The engagement of TOM receptors with cytoplasmic chaperones
that mediate the transition of precursor proteins from ribosomes
to mitochondria has been found to differ between species. In yeast,
interactions between Tom70 and hydrophobic precursors that
carry an internal sorting signal are regulated by cytosolic Hsp70.
In humans, a multichaperone complex of Hsp90 and Hsp70 deliv-
ers precursor proteins to TOMM70A for subsequent import [37]
(Fig. 2A). Additionally, the TOMM34 co-chaperone, which does
not have a yeast homologue, has been found to interact with the
Hsp70/Hsp90 complex [38,39] (Fig. 2A). As TOMM34–/– mice sus-
tain efﬁcient mitochondrial import, the function of TOMM34 as a
mitochondrial precursor chaperone remains to be clariﬁed [40].
Interestingly, TOMM20 was found to interact with the arylhydro-
carbon receptor-interacting protein (AIP), a cytosolic factor with
chaperone-like activity [41].
Classically, TOMM20 serves as a receptor for mitochondrial pro-
tein precursors that harbor an N-terminally localized targeting sig-
nal, whereas TOMM70A engages proteins that carry an internal
sorting signal [5,6]. Unlike in yeast, the translocation of human
precursor proteins from TOMM70A to the membrane channel is
assisted by TOMM20 and its afﬁnity for the precursor-binding tet-
ratricopeptide repeat (TRP) domain of TOMM70A [42] (Fig. 2A).
The human TOM complex contains the small TOMM5, TOMM6,
and TOMM7 proteins, which are involved in the assembly and sta-
bility of the core complex [43] (Fig. 2A). Interestingly, their func-
tion is not conserved within the eukaryotic kingdom. The yeast
TOM complex is stabilized by Tom6 and more dynamic or destabi-
lized by the presence of Tom7 [9–11]. In humans, the TOMM7 pro-
tein stabilizes TOM [43].
The SAMM50 protein, the main component of the SAM complex,
is conserved between yeast and metazoa [44] (Fig. 2A). It forms a
200 kDa complex in the OMM and participates in the insertion of
b-barrel proteins, such as VDAC and TOMM40. The human counter-
parts to the additional SAM components are the peripherally
OMM-associated Metaxin-2 (yeast Sam35) and Sam37-like
Metaxin-1 and Metaxin-3 [45–48]. Given their high sequence
divergence, clear structural similarity cannot be readily inferred
[48] (Fig. 2A). Only a small fraction of Metaxin-1 is present with
SAMM50 in the 200 kDa complex, whereas a larger fraction of
Metaxin-1 is found in a distinct complex of 600 kDa together with
Metaxin-2 [47].
3.2. Mitochondrial intermembrane space assembly
The oxidoreductase MIA40 (CHCHD4) and sulfhydryl oxidase
ALR (human Erv1, Augmenter of Liver Regeneration, hepatopoie-
tin, GFER) are the human orthologues of key constituents of the
yeast MIA pathway. The main difference between yeast and
Fig. 2. Similarities and differences between yeast and humans in the architecture and function of mitochondrial translocases. Translocase components that are evolutionarily
conserved are represented in gray, with name differences in pink where indicated. Components that are found only in yeast are in blue, and human-speciﬁc proteins are
represented in pink. In cases in which more than one paralogue of the human protein exist, both names are given (e.g., 17A/17B). The high sequence divergence between
human Metaxin proteins and yeast Sam35/37 might result in a difference in structure or function; therefore, these are shown as individual proteins, represented in pink and
blue, respectively. OMM, outer mitochondrial membrane; IMS, intermembrane space; IMM, inner mitochondrial membrane; Dw, electrochemical potential of the inner
mitochondrial membrane; TOM, translocase of the outer membrane; SAM, sorting and assembly machinery; MIM, insertase of the mitochondrial outer membrane; e,
electron; TIM23, presequence translocase; PAM, presequence translocase-associated motor; TIM22, carrier translocase of the inner membrane.
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Human MIA40 lacks the N-terminal portion, including the prese-
quence and transmembrane segment. This change results in a
difference in the topology of these two proteins. Yeast Mia40 is
IMM-anchored, whereas human MIA40 is soluble in the IMS
[49,50] (Fig. 2B). Nonetheless, the C-terminal domains of human
and yeast Mia40 have a high level of similarity, including the
conserved CPC and twin CX9C motifs. Because of the lack of a
presequence, human MIA40 is imported into the IMS via the
MIA pathway [50]. Similar to other MIA pathway substrates,
human MIA40 trapping in the IMS relies on the oxidation of cys-
teine residues in the twin CX9C motifs [49]. This mechanism is
analogous to the import of an artiﬁcial presequence and trans-
membrane domain-lacking Mia40 protein in yeast [50]. Reconsti-
tution of the human MIA pathway in yeast cells conﬁrmed the
high functional conservation of MIA40 and ALR function within
the eukaryotic kingdom. Although deprived of the N-terminalsegment, human MIA40 was correctly localized to yeast mito-
chondria and able to substitute for the essential function of yeast
oxidoreductase in the biogenesis of IMS proteins, including their
recognition, formation of intermediates, and oxidation in
cooperation with ALR [51]. Additionally, a novel role for ALR in
the mitochondrial accumulation of human MIA40 has been
reported [51].
The in vivo studies that have been performed in mammalian
cells showed that the oxidation-driven import of IMS-targeted pre-
cursor proteins is much slower than presequence-dependent
translocation, and its efﬁciency strongly depends on the accessibil-
ity of fully functional human MIA40. Manipulating the amount of
oxidoreductase showed that MIA40 is a ‘‘bottle neck’’ for oxidative
folding in the IMS in intact mammalian cells [52]. Interestingly, in
human cells, MIA40 is present in two ubiquitously expressed splic-
ing isoforms that differ by a short stretch of N-terminally located
amino acid residues [49,53].
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part, has a FAD prosthetic group. Both oxidation by MIA40 and
interactions with FAD were suggested to determine the mature
conformation of ALR and its entrapment in the IMS [54]. Interest-
ingly, ALR has two splicing variants, 23 kDa and 15 kDa, that differ
by 80 amino acids at the N-terminus. The cysteine residues and
FAD binding domain are conserved and found in both isoforms,
but the shorter isoform functions extracellularly as a mitogen
and intracellularly as an intracrine of cytosolic and nuclear locali-
zation [55–57]. How the partitioning of both isoforms between
various compartments is achieved remains unclear.
3.3. Translocases of the inner membrane
The general architecture of the TIM23 complex and topology of
its major components are conserved between species [58] (Fig. 2C).
Human TIMM23, TIMM50, TIMM17, and TIMM44 have high simi-
larity to their yeast counterparts (Fig. 2C). Interestingly, in humans,
the gene that encodes TIMM17 occurs in two copies. Both
TIMM17A and TIMM17B are ubiquitously expressed in human tis-
sues and able to assemble into the TIM23 complex. However, they
are separated into different subpopulations of the complex because
they do not co-precipitate with each other [58,59].
The function of the import motor in humans is also evolution-
arily conserved. MAGMAS, an orthologue of Pam16, can comple-
ment the growth of Pam16-deﬁcient yeast [60]. Pam18 has two
orthologues in the human genome, MCJ and DNAJC19 [61,62]
(Fig. 2C). Both proteins stimulate the ATP-ase activity of
mtHsp70/Mortalin and interact with the TIM23 complex [60,62].
Although both proteins are ubiquitously expressed in human tis-
sues, they are not fully interchangeable functionally [59]. MCJ,
but not DNAJC19, was able to restore the viability of
Pam18-depleted yeast cells [62]. In fact, DNAJC19was found to pre-
dominantly interact with the prohibitin complexes and to regulate
cardiolipin metabolism (Thomas Langer, personal communication).
Mutations in DNAJC19 result in pathology [61,63]. Interestingly,
MCJ has been recently found to regulate the activity of respiratory
complex I and its engagement in the supercomplexes [64].
In yeast, Tim21 interacts with Tim23 through the Mgr2 protein,
which is an orthologue of human ROMO1. ROMO1 is involved in
the mitochondrial processing of the optic atrophy 1 (OPA1) pro-
tein, and its activity has been implicated in the control of mito-
chondrial dynamics and reactive oxygen species (ROS)-induced
signaling [65,66]. Fully assembled respiratory chain complexes in
humans are not directly connected to the TIM23 complex. None-
theless, human TIMM21 was found in the recently identiﬁed
MITRAC (mitochondrial translation regulation assembly interme-
diate of cytochrome c oxidase) complex, together with assembly
intermediates of respiratory chain complexes [67] (Fig. 2C). The
fact that TIMM21 is found in complexes with MITRAC and that
MCJ is involved in the control of the respiratory chain emphasizes
tight coupling between protein import machineries and abundant
IMM complexes devoted to respiration.
Human hydrophobic proteins with multiple internal targeting
signals are imported into the IMM via the TIM22 translocase. How-
ever, in contrast to other translocases, TIM22 differs substantially
between lower and higher eukaryotes (Fig. 2C). The core complex
of yeast TIM22 is composed of Tim22, Tim18, Tim54, and Sdh3 pro-
teins (Fig. 1C). Tim22 and Sdh3 are the only proteins from the
TIM22 complex that are present in human cells. No evidence to
date indicates that Sdh3 interacts with the TIM22 translocase in
humans. TIMM22 itself exhibits substantial conservation, suggest-
ing that it cooperates with yet unknown partners [68] (Fig. 2C).
On the IMS side, the TIM22 complex interacts with small Tim
proteins that shuttle precursor proteins from TOM to TIM22. Inyeast, small Tim proteins form three complexes: a soluble Tim9-
Tim10 complex, Tim9-Tim10-Tim12 associated with the core
TIM22 complex, and a soluble Tim8-Tim13 complex. Tim12 is a
yeast-speciﬁc duplication of yeast Tim10 [68–70] that interacts
with TIM22. In humans (Fig. 2C), this function is fulﬁlled by the
metazoan-speciﬁc TIMM10B (similar to yeast Tim9 and human
TIMM9) [70]. TIMM10B forms a complex with TIMM9 and
TIMM10, also referred to as Tim10a, and is present in the complex
with TIMM22 [69]. TIMM10 and TIMM9 also form a separate com-
plex without TIMM10B [69]. TIMM8 and TIMM13 have two para-
logues in the human genome. TIMM8A is ubiquitously expressed,
whereas TIMM8B mRNA was found at elevated levels in the heart,
liver, and skeletal muscle, although its presence at the protein level
was not conﬁrmed [71]. TIMM13A is expressed mainly in the fetus,
whereas TIMM13B prevails in adults [71]. The functional features
of these proteins remain to be studied.
4. Regulatory functions of mitochondrial translocases
Several recent studies led to the proposal that the function of
the human MIA pathway extends beyond the framework of the
yeast system. The MIA pathway in humans promotes the mito-
chondrial localization of some non-IMS proteins that may be
conditionally targeted to mitochondria. An example is AP endonu-
clease 1 (APE1), a nuclear protein of the DNA base excision repair
pathway that is localized to the mitochondrial matrix where it
participates in mtDNA repair [72]. The localization of APE1 to mito-
chondria requires cysteine residue C65 and redox-assisted folding
that is attributed to the MIA pathway where APE1 is able to inter-
act with MIA40 [73]. Another example is the p53 protein, a tran-
scription factor and ‘‘guardian of the genome’’ of differentiated
cells that is implicated in broad stress-related signaling pathways
that ultimately affect cell cycle arrest, senescence, and apoptosis.
Mutations in the TP53 gene are the most frequently reported muta-
tions in cancer-related malignancies [74]. Interestingly, growing
evidence suggests that the levels of p53 and its subcellular locali-
zation control metabolism [75]. Oxidative stress leads to the
accumulation of p53 in mitochondria where it plays a role in main-
taining the integrity of the mitochondrial genome (Fig. 3A). The
transport of p53 to the mitochondrial matrix has been shown to
depend on MIA40 [76].
Human stem cells reside in hypoxic niches and energetically
rely on anaerobic glucose metabolism [77]. Nonetheless, mito-
chondrial homeostasis has been reported to be an essential factor
for sustaining the proliferative potential and survival of stem cells.
The chemical inhibition of Erv1/ALR induced apoptosis in human
embryonic stem cells (hESCs) but not differentiated cells [78].
Erv1/ALR knockdown decreased stem cell pluripotency and mito-
chondrial function because of a loss of membrane potential and
excessive fragmentation. At the molecular level, this can be
explained by the fact that a decrease in Erv1/ALR expression corre-
lates with an increase in dynamin-related protein 1 (Drp1) levels
and consequently a disturbance in mitochondrial fusion-ﬁssion
balance [79]. The role of Erv1/ALR in sustaining proliferative
growth may not be restricted to its mitochondrial function. Models
are discussed for the involvement in hepatocyte proliferation and
liver regeneration, which rely on the cytosolic, nuclear, and extra-
cellular localization of the shorter forms of Erv1/ALR and its role in
activating extracellular and internal signaling pathways [57,80,81].
Terminally differentiated cells produce a bulk of energy through
oxidative phosphorylation and the respiratory chain. Conse-
quently, cell differentiation should trigger mitochondrial biogene-
sis. Defects in this process can dramatically affect a developing
embryo. Consistent with these observations, abnormalities in the
amount and function of the components of mitochondrial
Fig. 3. Mitochondrial translocases as regulatory players in tumorigenesis and signaling. (A) Under basal conditions, p53 shuttles between the nucleus and cytosol and is
degraded by the ubiquitin-proteasome system. Oxidative stress prevents p53 degradation and leads to its accumulation in the nucleus and import into mitochondria. (B)
Intensively proliferating cancer cells overproduce the translocase components MIA40, TIMM50, TIMM17A, and mtHsp70/Mortalin. (C) In cancer, p53 is transported into
mitochondria. The increased import of p53 is linked to the overproduction of MIA40 and mtHsp70/Mortalin. (D) The stabilization of HIF1a is used to activate hypoxic
signaling. MIA40 controls the stability of HIF1a via an as-yet-unclear mechanism that may involve the biogenesis and activity of respiratory chain complexes. OMM, outer
mitochondrial membrane; IMS, intermembrane space; IMM, inner mitochondrial membrane; TOM, translocase of the outer membrane; TIM23, presequence translocase.
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silencing or inhibition of Erv1/ALR in zebraﬁsh led to abnormalities
in liver and heart development, respectively, without affecting
apoptosis [78,81]. Defects in TOMM22 protein, identiﬁed in the oli-
ver zebraﬁsh mutant, resulted in hepatocyte apoptosis that under-
lies the small liver phenotype [82]. TIMM50 mutant ﬂies were
signiﬁcantly smaller in size, and a detailed analysis of the cells
obtained from these mutants showed a reduction of proliferation
rates [83]. In the developing zebraﬁsh embryo, the incidence of
increased cell death caused by TIMM50 depletion results in neuro-
degeneration, reduced motility, and dysmorphic hearts [84]. The
growth defects observed in ﬂies and zebraﬁsh upon a reduction
of TIMM50 levels indicate the importance of TIM23 during the
early stages of development. TIMM23 homozygous knockout mice
are not viable, whereas TIMM23 heterozygotes exhibited a neuro-
logical phenotype with a severely reduced lifespan [85].
Interestingly, a recent report showed that the abundance of one
of the TIMM17 paralogues, TIMM17A, is reduced under stress
conditions [86]. Decreased TIMM17A resulted in the impaired
biogenesis of mitochondrial proteins that depend on TIM23 and
triggered a stress-induced signaling pathway that is related tothe mitochondrial unfolded protein response (mtUPR). This phe-
nomenon was proposed to increase the resistance to stress under
pathological conditions [86]. In summary, in addition to canonical
mitochondrial function in energy conversion, the examples dis-
cussed above support the regulatory role of mitochondrial protein
translocases at the cellular level.
5. Mitochondrial protein translocases: implications in human
pathologies
Because of the essential role of mitochondria in cells, it is not
surprising that impaired mitochondrial biogenesis results in cell
and tissue pathologies. The goal of this chapter is to review the
involvement of speciﬁc mitochondrial translocase components in
human diseases.
5.1. Cancer
Cancer cells are similar to stem cells since they metabolically
rely on the Warburg effect and utilize glycolysis over
oxidative phosphorylation to produce energy for growth [87].
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biogenesis pathways to tumor progression. The upregulation of
TIMM17A expression has been identiﬁed as a diagnostic marker
and poor prognosis factor for cancer [59,88,89] (Fig. 3B). A similar
scenario is observed for two other mitochondrial protein transloca-
tion components, mtHsp70/Mortalin and MIA40. The overexpres-
sion of human mtHsp70/Mortalin or MIA40 has been associated
with the incidence of various types of human cancer and poor sur-
vival prognosis [53,90–92] (Fig. 3B). A decrease in mtHsp70/Mort-
alin levels impaired tumor growth and, importantly, sensitized
cancer cells to chemotherapy and drug-induced senescence
[92,93].
Mutation variants of p53 in malignancies showmany molecular
and functional abnormalities, some of which are mitochondria-
related. First, p53 has been found to stimulate aerobic respiration;
therefore, p53 mutations in glycolytic cancer tissues may serve to
sustain non-aerobic metabolism [94]. Second, p53 plays a funda-
mental role in initiating programmed cell death, in which the
release of cytochrome c from mitochondria is a critical step. The
avoidance of apoptosis, a feature that cancer cells can acquire via
p53 mutations, is a well-known hallmark of cancer [87]. Interest-
ingly, mitochondrial translocase components, such as mtHsp70/
Mortalin, MIA40, and TIMM50, have a connection with p53.
mtHsp70/Mortalin interacts with both wildtype and mutant p53
and sequesters its function in stress-mediated cellular signaling
(Fig. 3C). This feature is exploited by cancer cells. Through the
excessive production of mtHsp70/Mortalin, cancer cells can escape
p53-mediated apoptosis [95]. A recent study reported that the
mitochondrial localization of p53 can be modulated by MIA40
expression and is respiration-driven [76] (Fig. 3C). p53 does not
look like a classical substrate protein for the MIA pathway [6],
but its interaction with MIA40 depends on the CPC motif of oxido-
reductase and the cysteine residue at position 135 in p53 [76].
Another interesting correlation has been found between TIMM50
and p53. The levels of TIMM50 were found to be elevated in cancer
cells that harbor speciﬁc mutations in the TP53 oncogene [96]
(Fig. 3B). TIMM50 downregulation makes cells more vulnerable
to death stimuli, a scenario that p53 mutant cancer cells can over-
come through TIMM50 overexpression [84,96]. A tempting specu-
lation is that the increased levels of protein translocation
components in cancer cells can prevent p53-mediated stress
responses that are typical for healthy cells by binding, oxidizing,
and sequestering p53 to mitochondria. Going one step further, pre-
venting an increase in MIA40, TIMM50, or mtHsp70/Mortalin
activity may be a possible step toward more effective cancer
therapies.
The role of MIA40 in cancer is not limited to an interplay with
p53. MIA40 has been proposed to promote the hypoxic response
that is required for metabolic adaptation and tumor angiogenesis
because of HIF1a stabilization (Fig. 3D). The mechanism by which
MIA40 inﬂuences HIF1a stability is unclear. At least three mito-
chondria-dependent mechanisms of HIF1a stabilization have been
described: (i) ROS generation by complex III of the respiratory
chain [97], (ii) elevated oxygen consumption by complex IV
[53,98], and (iii) increased concentration of the complex II sub-
strate succinate [99]. Whether MIA40 stabilizes HIF1a indirectly
by modulating the biogenesis and activity of the respiratory chain
or more directly through an as-yet-unidentiﬁed mechanism
requires further studies (Fig. 3D).
In conclusion, several components of protein translocases are
frequently upregulated in cancer. In addition to direct involvement
in the transport of proteins with known roles in cancer, such as
p53, the increased activity of single protein translocation may
likely result in an imbalance in mitochondrial protein biogenesis
and homeostasis and thus less directly modulate the cellular
responses to stimuli and stress.5.2. Genetically inherited mitochondrial syndromes
The vast majority of mitochondrial translocase components
have been found to be essential for life of a simple unicellular
organism, the yeast S. cerevisiae. The fact that very little pathogenic
mutations of the core components of these pathways have been
reported in higher eukaryotes, including humans, is not surprising.
Consistent with the fundamental role played by translocases in
yeast, such mutations likely lead to early prenatal lethality. The
known diseases caused by alterations in mitochondrial protein
translocases are extremely rare.
The ﬁrst mitochondrial disease that was associated with
impaired function of the mitochondrial import machinery is
human deafness dystonia syndrome, which leads to hearing loss,
mental retardation, and blindness [100]. This recessive, X-chromo-
some-linked condition was found to be caused by mutations that
result in the loss of deafness dystonia protein 1 (DDP1), subse-
quently identiﬁed as the small mitochondrial IMS chaperone
TIMM8A [100]. An analysis of patient samples revealed mutations
in the CX3C motif of TIMM8A [101,102], which are likely responsi-
ble for its MIA pathway-mediated oxidative folding and retention
in the IMS. Because of the improper folding, the mutant protein
can no longer assemble into a complex with TIMM13 and under-
goes rapid turnover [102,103]. The dramatic clinical phenotype
that results from TIMM8A mutations underscores the signiﬁcance
of the oxidative folding of IMS proteins, which further impacts
downstream mitochondrial protein biogenesis.
An homozygous R194H mutation in sulfhydryl oxidase Erv1/
ALR was identiﬁed in patients diagnosed with infantile autosomal
recessive myopathy (ARM) [104]. This condition is phenotypically
characterized by congenital cataract, muscle hypotonia, hearing
loss, and developmental delay [104]. The R194H mutation affects
the stability of Erv1/ALR and enhances its degradation [105]. At
the cellular level, the Erv1/ALR mutation leads to the inefﬁcient
import of MIA pathway substrates, including components of the
respiratory chain. A decrease in the activity of respiratory com-
plexes is consequently observed, in addition to abnormal mito-
chondrial structure and accelerated mtDNA degeneration [104].
Using a yeast model with a reconstituted human MIA pathway,
the molecular basis of the disease was better deﬁned. A patholog-
ical mutation in the sulfhydryl oxidase Erv1/ALR affects the mito-
chondrial accumulation of human MIA40, resulting in the
impaired biogenesis of other MIA substrates [51].
Patients who suffer from Pelizaeus-Merzbacher disease (PMD),
in addition to rodent models of PMD, carry mutations in the PLP
gene. This gene encodes the proteolipid protein (PLP) and its shorter
isoform DM20, the twomost abundant membrane proteins in mye-
lin [106]. The consequences of disease-related PLP gene duplication,
which are phenotypically more severe than null mutations, include
the accumulation of PLP in mitochondria. At the molecular level,
PMD is characterized by metabolic abnormalities as a possible con-
sequence of overexpressed PLP localization to mitochondria
[107,108]. Interestingly, overexpressed PLP that carried cysteine-
to-alanine mutations in the N-terminally located CX3C and CX9C
motifs was no longer targeted to mitochondria, but its ability to
localize to the plasmamembrane remained unchanged [108]. These
observations suggest the possible involvement of Mia40 [109] in
themitochondrial import of PLP in PMD. Further studies are needed
to better understand the disease-linked localization of PLP in mito-
chondria, involvement of Mia40, and mechanisms by which this
abnormal PLP behavior alters physiology.
5.3. Role of mitochondrial protein translocases in neurodegeneration
Frequently, neurodegenerative diseases have a late onset, with
sporadic deterioration of various types of neuronal cells. The
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genetically. Over one-third of the genetic mutations associated
with the inherited predisposition to neurodegeneration are func-
tionally linked to mitochondria [110,111]. Furthermore, the symp-
toms of many, or perhaps all, types of neurodegeneration include
various modes of mitochondrial dysfunction. Here, we focus on
the aspects of these devastating pathologies that are directly or
indirectly related to mitochondrial protein translocases at the
molecular level.
5.3.1. Parkinson’s disease
To sustain cellular homeostasis in the context of such dynamic
organelles as mitochondria, maintaining their continuous biogene-
sis and removing damaged pools are equally important. A failure of
mitochondria quality control at the organellar level has been
reported to be a predisposing factor to Parkinson’s disease (PD)
[111,112]. A subpopulation of patients who suffer from the familial
form of PD carry loss-of-function mutations in the PTEN-induced
putative kinase-1 (PINK1) and PARK2 genes. PARK2 encodes Parkin
E3-ubiquitin ligase, which is involved in mitochondrial turnover
[113].
In the case of mitochondrial dysfunction with the hallmark
decrease in electrochemical IMM potential, the PINK1-Parkin path-
way is responsible for marking damaged mitochondria for degra-
dation by selective autophagy [112]. Under physiological
conditions, PINK1 is synthesized in the cytosol as a 63 kDa precur-
sor that, upon relocating to mitochondria, is processed into the
mature 52 kDa form and subsequently degraded. Thus, Parkin is
not recruited to healthy mitochondria. Under stress conditions that
are experimentally mimicked by treatment with uncouplers to dis-
sipate IMM potential, the import of PINK1 differs such that the
unprocessed form is released to the OMM and recruits cytosolically
located Parkin instead of being targeted to degradation. The role of
the TOM complex or its single components in the import of PINK1
into mitochondria is commonly known. PINK1 was found in com-
plex with TOM or its components [114–117]. However, still
unclear are the TOM components on which the import pathway
of PINK1 relies in healthy and damaged mitochondria. Importantly,
an unbiased approach identiﬁed TOMM7 as a functionally relevant
factor that is involved in anchoring and stabilizing PINK1 kinase on
damaged mitochondria [118]. Interestingly, the impaired mito-
chondrial import through the TOM complex was shown to play a
pivotal role in activating PINK1-Parkin-dependent mitochondrial
clearance [116]. Consistent with this observation, TOMM40 (i.e.,
the core component of the TOM complex) was found to be down-
regulated in midbrain samples from PD patients and mouse models
of PD [119]. Furthermore, TOM components, similar to many other
OMM proteins, are the ubiquitination targets of Parkin upon its
recruitment to mitochondria [120]. Remaining questions are
whether TOM activity is a decisive step in activating the mitochon-
drial clearance pathway and the extent to which it contributes to
PD.
5.3.2. Alzheimer’s disease
Alzheimer’s disease (AD) is the most frequent age-related disor-
der, characterized by the gradual accumulation of neuronal abnor-
malities that result in progressive dementia in patients. Growing
evidence indicates that mitochondrial defects contribute to the
neuronal cell pathologies observed in patients and experimental
models of AD [111,121]. These defects include increased ROS pro-
duction, the fragmentation of mitochondria, and the decreased
activity of canonical mitochondrial processes, such as oxidative
phosphorylation [121]. In addition to other typical features, such
as the accumulation of hyperphosphorylated Tau protein and dis-
turbed calcium homeostasis, AD is accompanied by an accumula-
tion of amyloid b (Ab) peptide, a proteolytic product of theamyloid precursor protein (APP) [121]. Interestingly, studies that
mimicked AD pathology by chronically exposing human cells to
Ab peptide reported blockage of the TOM channel for the import
of mitochondria-targeted proteins [122]. Indeed, Ab peptide enters
mitochondria through the TOM channel, and its import is indepen-
dent of mitochondrial membrane potential [123]. Studies on the
submitochondrial localization of Ab peptide using in vitro import
experiments and AD patient biopsies revealed that Ab peptide
resides within cristae, the folds of the IMM, and is cleared from
mitochondria by the redox-regulated peptidase PreP [123].
Whether the pathology observed in AD can be modulated by regu-
lating the uptake and stability of Ab peptide inside mitochondria is
an important question for future studies.
5.3.3. Huntington’s disease
This neurodegenerative disease is genetically inherited and
caused by the expansion of polyglutamine repeats in the hunting-
tin protein. This fatal disease is additionally linked to mitochon-
drial dysfunction [110,111]. The list of mitochondrial
abnormalities found in neurons in HD patients and mouse models
is complex. Examples include impaired glucose metabolism and a
defective respiratory chain [110,111]. The levels of Erv1/ALR pro-
tein have recently been reported to be substantially decreased in
mouse heterozygous or homozygous huntingtin mutant striatal
cells, with either unchanged or slightly reduced MIA40 levels
[124]. Consequently, the substrates of the MIA pathway and com-
ponents of respiratory chain complex I, NDUFB7 and NDUFS5, were
signiﬁcantly altered, indicating problems with complex I assembly
and activity and reduced oxidative phosphorylation [124].
5.3.4. Amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is a devastating disease that
affects motor neurons [111,125,126]. Its genetically inherited cases
are frequently associated with mutations in Sod1, an enzyme
responsible for ROS scavenging [125,126]. The disease-causing fac-
tor is not the inability to neutralize ROS but rather the formation of
toxic protein Sod1 aggregates. Although most Sod1 is found in the
cytosol, a small pool is localized to the IMS of mitochondria. Thus,
in the context of Sod1 the mitochondrial dysfunction observed in
ALS is not surprising [125,126]. To be retained in the IMS, Sod1
requires Ccs1, a copper chaperone that is also involved in the oxi-
dation of Sod1. In yeast, the localization of Ccs1 depends on the
MIA pathway [127,128]. In human cells, the situation is less clear,
but two possible scenarios have been proposed. The ﬁrst scenario
implies a role for MIA40, and the second scenario suggests the sole
involvement of Ccs1 in the import of Ccs1 to the IMS [129,130].
Interestingly, Kawamata and Manfredi found that the mechanisms
that drive the IMS localization of mutant versions of Sod1 in
human cells differ from wildtype Sod1 [129]. In yeast, studies on
Sod1 with conserved amino acid substitutions that cause ALS in
humans supported and extended the view of unique pathways
for pathogenic variants of Sod1 [131]. Disease-related forms of
Sod1 that fail to undergo oxidation are localized to the IMS
[131]. Interestingly, the import of these Sod1 variants and reduced
wildtype Sod1 did not depend on Ccs1. Instead, this process relied
on the unconventional action of Mia40 that did not result in disul-
ﬁde bond formation [131]. The lack of MICOS, the mitochondrial
contact site and cristae-organizing system that affects the architec-
ture of mitochondria, was found to increase the mitochondrial lev-
els of wildtype oxidized Sod1. Intriguingly, the depletion of one
MICOS component, Mic60 (Fcj1/Mitoﬁlin), led to the accumulation
of reduced aberrant forms of Sod1 [131]. Thus, Mia40 and MICOS
are novel factors that affect the biogenesis of pathogenic variants
of Sod1 in simple eukaryotic cells. Future studies will assess
whether these proteins are also important in the pathology of
ALS. Independent of which pathway the conformationally altered
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import of proteins into spinal cord mitochondria [132].
6. Concluding remarks
Undeniably, mitochondria are essential for life. Protein
translocases are fundamental players in the effective biogenesis
of mitochondria. Interestingly, growing evidence indicates the
involvement of mitochondrial translocase components in human
pathologies and cancer. A tempting speculation is that the mito-
chondrial transport components that have been found to be upreg-
ulated in cancer may become new targets for drugs, which can
potentiate anti-cancer therapies in the future. Recent studies
greatly expanded the view on the role of the MIA pathway in the
cell by identifying its function in hypoxic signaling and the condi-
tional stress-regulated mitochondrial transport of proteins, which
have important canonical functions beyond mitochondria. An aris-
ing theme involves alterations in mitochondrial translocases and
protein import in various types of neurodegeneration. Disturbed
protein homeostasis is a common hallmark of neurodegenerative
pathologies, thus it is tempting to speculate that the reduced efﬁ-
ciency of mitochondrial protein import, which is deleterious to cel-
lular proteostasis, may be an important process that contributes to
these pathologies. Future research should provide insights into the
links and networks that involve dynamic mitochondrial protein
transport and biogenesis processes that are responsible for the
health of the cell and entire organism.
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